Cancel
Known information
- Has over 25 years of biopharmaceutical commercial experience in both strategic and operational capacities
- Served as the Vice President of Global Marketing and Commercial Operations at Chiasma Pharma, where he built a team responsible for launching the company's first product for a rare disease
- Led a global team at Alexion Pharmaceuticals to prepare for the commercialization of Ultomiris and for the marketing of Soliris in two ultra-rare hematology diseases
- Previously worked for 12 years at Boehringer Ingelheim in the U.S. and Germany holding leadership roles of increasing responsibility spanning product launches, new product planning, and market access
- Began his career as a management consultant at Accenture
- Received an MBA from The Tuck School of Business at Dartmouth College and a bachelor's degree in cellular structure and function and in economics from Middlebury College
- Spends time with his wife and two boys, ideally outside, when not working
- Favorite animal is his canine hiking companion, Bromley
- Grew up on Long Island, NY and spent summers in Southern VT
About Rallybio
Rallybio develops therapies for rare diseases, with a diversified portfolio and multinational clinical trials.
Report inaccurate information
